Efficacy of High and Low Intensity Percutaneous Electrolysis for the Treatment of Myofascial Pain Syndrome

May 13, 2020 updated by: Universidad Francisco de Vitoria

Efficacy of High and Low Intensity Percutaneous Electrolysis for the Treatment of Myofascial Pain Syndrome: A Pilot Study

Muscle pain is frequently attributed to myofascial pain syndrome (MPS) in which myofascial trigger points (MTrP) are a characteristic feature. Dry needling is a frequent clinical practice to manage MPS but few evidence is published about percutaneous electrolysis effects for the treatment of MPS.

This is a randomized clinical trial with 3 parallel groups: 1) High intensity-short time percutaneous electrolysis; 2) Low intensity-long time percutaneous electrolysis; 3) dry needling control group.

Study Overview

Detailed Description

The current study aimed to evaluate changes in rectus femurs active trigger points and patellar tendon pain pressure thresholds and subjective anterior knee pain perception after application of two percutaneous electrolysis methods using a same charge (high intensity and low intensity) compared to a dry needling group in patients with patellofemoral pain syndrome (PFPS)

Fifteen patients diagnosed with unilateral PFPS were divided in two experimental groups (high intensity percutaneous electrolysis and low intensity percutaneous electrolysis) and one active control group (dry needling. The duration of the study was 7 days with only one intervention. Pain pressure thresholds were assessed using an algometer before the intervention, immediately after the intervention and after 7 days and a Visual Analogue Scale was used before the treatment and after 7 days to rate the subjective anterior knee pain perception. Also a VAS was used to rate the pain perception during the intervention

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Madrid
      • Villanueva de la Cañada, Madrid, Spain, 28692
        • Camilo Jose Cela University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Athletes with knee pain
  • Presence of at least one active Trigger point

Exclusion Criteria:

  • Farmacologic treatment
  • Surgery or traumas
  • Skin alterations or infections
  • Prior 6 weeks DN nor PT treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: High-Intensity short time percutaneous electrolysis
Application of a 0,66uA galvanic current in the active TrP through a needle during 10 seconds. During the 20 seconds left necessary to blind the patient and the examiner, the needle was inside but with no electrical current
Needle emplacement with a galvanic electrical current
EXPERIMENTAL: Low-Intensity long time percutaneous electrolysis
Application of a 0,22uA galvanic current in the active TrP through a needle during 30 seconds
Needle emplacement with a galvanic electrical current
ACTIVE_COMPARATOR: Dry needling
One acupuncture needle was placed in the active TrP to produce a local twitch response during 30 seconds
Needle emplacement without electrical current nor substance

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pressure Pain Threshold (Trigger Point)
Time Frame: 7 days
Algometry (Wagner analogical algometer)
7 days
Pressure Pain Threshold (Patellar Tendon)
Time Frame: 7 days
Algometry (Wagner analogical algometer)
7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective pain perception
Time Frame: 7 days
Visual Analogue Scale
7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Juan Antonio Valera-Calero, PT, Msc, Camilo Jose Cela University
  • Study Director: Alberto Sanchez-Mayoral-Martín, PT, Free professional practice

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 17, 2020

Primary Completion (ACTUAL)

March 30, 2020

Study Completion (ACTUAL)

April 27, 2020

Study Registration Dates

First Submitted

April 30, 2020

First Submitted That Met QC Criteria

May 13, 2020

First Posted (ACTUAL)

May 15, 2020

Study Record Updates

Last Update Posted (ACTUAL)

May 15, 2020

Last Update Submitted That Met QC Criteria

May 13, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muscle Pain

Clinical Trials on Percutaneous Electrolysis

Subscribe